HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE

PANITUMUMAB

Panitumumab, a recombinant, human IgG2 kappa monoclonal antibody that binds to the epidermal growth factor receptor (EGFR), blocks the addition of a phosphoryl group and the activation of intracellular tyrosine kinases. This leads to the arrest of cell growth, proliferation, transformation, and general longevity of tumor cells.

Use this medication precisely as recommended by your physician. Follow the prescription of your doctor carefully.

The medication dose your physician has given is based on your condition, other medications or food supplements you may take, and your reaction to treatment. To diminish your risks for adverse effects, don’t increase your dosage, take it regularly, or take it as instructed by your physician. Adverse events may still happen even at usual prescription dosages.

If your physician requests you to use this drug consistently, use it regularly to get the most benefits from it. To make you remember it better, take it at a fixed time every day.

Your doctor may need to modify your dosages to ease your symptoms or if you develop adverse reactions.

If you have any inquiries with regards to information, ask your physician or pharmacist.

    • Wild-type RAS metastatic colorectal cancer

    This medicine may be recommended for different uses. Approach your physician or pharmacist for more information.

     

  • Do not use Panitumumab in people with the following conditions:
    • Interstitial pneumonitis or pulmonary fibrosis
    • RAS mutation-positive metastatic colorectal cancer or unknown RAS mutation status
    • Lactation
    • Concomitant use of bevacizumab-containing and IFL (irinotecan, 5-fluorouracil and leucovorin)-containing chemotherapy.

     

Panitumumab may have the following side effects:

  • Fever
  • Chills
  • Hypotension
  • Photosensitivity
  • Erythema
  • Pruritus
  • Rash
  • Dry skin
  • Skin fissures
  • Skin exfoliation
  • Acneiform dermatitis
  • Paronychia
  • Local abscesses
  • Electrolyte depletion
  • Hypomagnesemia
  • Hypokalemia
  • Keratitis or ulcerative keratitis

Keep in mind that your physician has recommended this drug since he or she has known that the advantage to you is more noteworthy than the risk of adverse reactions. Many individuals utilizing this medicine don’t have serious side effects.

A serious allergy to this medication is uncommon. In any case, seek emergency medical help if you see any manifestations of a serious allergic response, including a rash, tingling or swelling particularly of the face or tongue or throat, dizziness or difficulty in breathing.

This is is not a complete list of side effects. If you see other effects not recorded above, contact your physician or pharmacist.

 

Take extra caution in patients with the following medical conditions:

  • Patient with history of keratitis, ulcerative keratitis or severe dry eye
  • Pregnancy

Prior to taking this medicine, tell your physician or pharmacist if you are allergic to it, or if you have some other hypersensitivities. This drug may contain inert ingredients which can cause unfavorable side effects or different issues. Talk with your pharmacist for more information.

 

Interactions

Panitumumab may interact with the following medicines:

  • Bevacizumab-containing chemotherapy
  • IFL-containing chemotherapy

Inform your physician about the drugs you take including over-the-counter medications, prescribed drugs, supplements and vitamins.

This is not a complete list of drug interactions. Approach your physician or pharmacist for more details.

The effects of certain medications can change if you consume different medications or herbal products simultaneously. This can build your risk for side effects or may cause your drugs not to work effectively. These interactions are conceivable, yet don’t generally happen. Your physician or pharmacist can prevent or oversee interactions by changing how you utilize your prescriptions or by close checking.

While utilizing this drug, don’t start, stop, or change the dose of other medicines you are using without your physician’s advice.

If you think you have used Panitumumab more than the usual dosage, please seek medical help immediately.

 

Available Brand:

  • Vectibix

 

Related Articles

ULTRAVIST

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultravist is used in the following conditions: Radiographic Imaging: Iopromide injection is utilized to enhance the [...]

ULTRAMOX

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultramox is used in the following conditions: Respiratory Infections: Amoxicillin is often used to treat respiratory [...]

ULTRALIV

UsesWarningsSide EffectsPrecautionsOverdose & BrandsUses Ultraliv is used in the following conditions: Carnitine Orotate: Carnitine orotate is a combination of L-carnitine [...]